SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-22-309203
Filing Date
2022-12-20
Accepted
2022-12-20 16:58:30
Documents
10

Document Format Files

Seq Description Document Type Size
1 POS AM d601359dposam.htm POS AM 303795
2 EX-23.1 d601359dex231.htm EX-23.1 2157
3 EX-23.2 d601359dex232.htm EX-23.2 2277
4 EX-23.3 d601359dex233.htm EX-23.3 2282
5 GRAPHIC g601359g04u00.jpg GRAPHIC 39418
6 GRAPHIC g601359g09o04.jpg GRAPHIC 103927
7 GRAPHIC g601359g10q00.jpg GRAPHIC 57254
8 GRAPHIC g601359g10y00.jpg GRAPHIC 86107
9 GRAPHIC g601359g11h00.jpg GRAPHIC 49833
10 GRAPHIC g601359g31p00.jpg GRAPHIC 53486
  Complete submission text file 0001193125-22-309203.txt   821526
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-267626 | Film No.: 221475544
SIC: 2834 Pharmaceutical Preparations